{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["diabetic nephropathy", "glycated hemoglobin A1c", "green tea", "kidney function", "lipid profiles"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38162524", "DateRevised": {"Year": "2024", "Month": "01", "Day": "03"}, "Article": {"Language": ["eng"], "ELocationID": ["1253275", "10.3389/fnut.2023.1253275"], "ArticleDate": [{"Year": "2023", "Month": "12", "Day": "14"}], "Journal": {"ISSN": "2296-861X", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in nutrition", "ISOAbbreviation": "Front Nutr"}, "ArticleTitle": "The effect of green tea (<i>Camellia sinensis</i>) on lipid profiles and renal function in people with type 2 diabetes and nephropathy: a randomized controlled clinical trial.", "Pagination": {"StartPage": "1253275", "MedlinePgn": "1253275"}, "Abstract": {"AbstractText": ["Diabetic nephropathy is one of the most important microvascular complications of diabetes. Despite the modern treatments, herbs or medicinal plants have gained wide attention. One of these herbs is green tea (<i>Camellia sinensis</i>), which may have an impact on renal function, lipid profiles, and HbA1c. However, the evidence for this is unclear and limited. The present study aimed to evaluate the effect of different doses of green tea on these parameters in type 2 diabetes patients (T2DM) with nephropathy.", "Sixty-six individuals with T2DM nephropathy (aged 30-70 years) were randomly assigned to receive three cups of green tea/day (<i>n</i> = 22), two cups of green tea/day (<i>n</i> = 22), and the control group (<i>n</i> = 22) for 12 weeks. Lipid profiles, glycated hemoglobin A1c (HbA1c), and renal markers were measured before and after intervention. Data were analyzed using SPSS software version 23. One-way analysis of variance (ANOVA), least significant difference (LSD) <i>post hoc</i>, and analysis of covariance were used to compare quantitative variables.", "In total, 64 participants completed the study. Consuming three cups of infusion green tea per day (7.5 gr) led to a significant reduction in serum levels of total cholesterol (<i>p</i> = 0.009) and HbA1c (<i>p</i> = 0.006) and increased in high-density lipoprotein cholesterol (HDL-C) (<i>p</i> = 0.02) compared with the control group who did not drink green tea. However, no significant differences were observed for other variables.", "In general, it was found that drinking three cups of green tea infusion (7.5 gr) per day produced beneficial effects on some lipid profiles and HbA1c without any adverse effects on renal function in patients with T2DM nephropathy. More studies are needed to fully elucidate these findings.", "Iranian Registry of Clinical Trials (www.irct.ir) under registry number: IRCT2014020114538N2."], "CopyrightInformation": "Copyright \u00a9 2023 Yazdanpanah, Salehi-Abargouei, Mozaffari and Hemayati."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Food Hygiene and Safety, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}, {"Identifier": [], "Affiliation": "Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}], "LastName": "Yazdanpanah", "ForeName": "Zeinab", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Food Hygiene and Safety, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}, {"Identifier": [], "Affiliation": "Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}, {"Identifier": [], "Affiliation": "Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}], "LastName": "Salehi-Abargouei", "ForeName": "Amin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}], "LastName": "Mozaffari", "ForeName": "Zohre", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}, {"Identifier": [], "Affiliation": "Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}], "LastName": "Hemayati", "ForeName": "Roya", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Nutr", "NlmUniqueID": "101642264", "ISSNLinking": "2296-861X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ritz E, Rychl\u00edk I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis. (1999) 34:795\u2013808.", "ArticleIdList": ["10561134"]}, {"Citation": "Gross JL, De Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care. (2005) 28:164\u201376.", "ArticleIdList": ["15616252"]}, {"Citation": "Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis. (1999) 33:1004\u201310. 10.1016/s0272-6386(99)70442-7", "ArticleIdList": ["10.1016/s0272-6386(99)70442-7", "10213663"]}, {"Citation": "Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. Br Med J. (2000) 321:405\u201312. 10.1136/bmj.321.7258.405", "ArticleIdList": ["10.1136/bmj.321.7258.405", "PMC27454", "10938048"]}, {"Citation": "Riley MD, Dwyer T. Microalbuminuria is positively associated with usual dietary saturated fat intake and negatively associated with usual dietary protein intake in people with insulin-dependent diabetes mellitus. Am J Clin Nutr. (1998) 67:50\u20137. 10.1093/ajcn/67.1.50", "ArticleIdList": ["10.1093/ajcn/67.1.50", "9440375"]}, {"Citation": "Mora C, Navarro JF. Inflammation and diabetic nephropathy. Curr Diabetes Rep. (2006) 6:463\u20138.", "ArticleIdList": ["17118230"]}, {"Citation": "Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med. (1998) 158:998\u20131004. 10.1001/archinte.158.9.998", "ArticleIdList": ["10.1001/archinte.158.9.998", "9588433"]}, {"Citation": "Newman DJ, Cragg GM, Snader KM. The influence of natural products upon drug discovery. Nat Product Rep. (2000) 17:215\u201334.", "ArticleIdList": ["10888010"]}, {"Citation": "Lin Y-L, Juan I-M, Chen Y-L, Liang Y-C, Lin J-K. Composition of polyphenols in fresh tea leaves and associations of their oxygen-radical-absorbing capacity with antiproliferative actions in fibroblast cells. J Agric Food Chem. (1996) 44:1387\u201394."}, {"Citation": "Higdon JV, Frei B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. (2003) 43:89\u2013143.", "ArticleIdList": ["12587987"]}, {"Citation": "Meng J-M, Cao S-Y, Wei X-L, Gan R-Y, Wang Y-F, Cai S-X, et al. Effects and mechanisms of tea for the prevention and management of diabetes mellitus and diabetic complications: An updated review. Antioxidants. (2019) 8:170\u201394. 10.3390/antiox8060170", "ArticleIdList": ["10.3390/antiox8060170", "PMC6617012", "31185622"]}, {"Citation": "Li X, Wang W, Hou L, Wu H, Wu Y, Xu R, et al. Does tea extract supplementation benefit metabolic syndrome and obesity? A systematic review and meta-analysis. Clin Nutr. (2020) 39:1049\u201358. 10.1016/j.clnu.2019.05.019", "ArticleIdList": ["10.1016/j.clnu.2019.05.019", "31174941"]}, {"Citation": "Bogdanski P, Suliburska J, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res. (2012) 32:421\u20137. 10.1016/j.nutres.2012.05.007", "ArticleIdList": ["10.1016/j.nutres.2012.05.007", "22749178"]}, {"Citation": "Kamiya Y, Iwai S, Nara K, Okazaki M, Oguchi K. Effects of green tea on matrix metalloproteinases in streptozotocin-induced diabetic rats. J Clin Biochem Nutr. (2005) 37:77\u201385."}, {"Citation": "Vaz SR, de Amorim LMN, de Nascimento PVF, Veloso VSP, Nogueira MS, Castro IA, et al. Effects of green tea extract on oxidative stress and renal function in diabetic individuals: A randomized, double-blinded, controlled trial. Junct Foods. (2018) 46:195\u2013201."}, {"Citation": "Borges CM, Papadimitriou A, Duarte DA, De Faria JML, De Faria JBL. The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial. Sci Rep. (2016) 6:28282. 10.1038/srep28282", "ArticleIdList": ["10.1038/srep28282", "PMC4913255", "27320846"]}, {"Citation": "Chen I-J, Liu C-Y, Chiu J-P, Hsu C-H. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial. Clin Nutr. (2016) 35:592\u20139.", "ArticleIdList": ["26093535"]}, {"Citation": "Cobos-Carbo A, Augustovski F. Declaraci\u00f3n CONSORT 2010: Actualizaci\u00f3n de la lista de comprobaci\u00f3n para informar ensayos cl\u00ednicos aleatorizados de grupos paralelos. Med Cl\u00edn. (2011) 137:213\u20135.", "ArticleIdList": ["21239025"]}, {"Citation": "World Medical Association. World medical association declaration of helsinki: Ethical principles for medical research involving human subjects. JAMA. (2013) 310:2191\u20134.", "ArticleIdList": ["24141714"]}, {"Citation": "Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. (1972) 18:499\u2013502.", "ArticleIdList": ["4337382"]}, {"Citation": "Hagstr\u00f6mer M, Oja P, Sj\u00f6str\u00f6m M. The International Physical Activity Questionnaire (IPAQ): A study of concurrent and construct validity. Public Health Nutr. (2006) 9:755\u201362.", "ArticleIdList": ["16925881"]}, {"Citation": "Suliburska J, Bogdanski P, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A. Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res. (2012) 149:315\u201322. 10.1007/s12011-012-9448-z", "ArticleIdList": ["10.1007/s12011-012-9448-z", "PMC3501173", "22581111"]}, {"Citation": "Sakpal TV. Sample size estimation in clinical trial. Perspect Clin Res. (2010) 1:67\u20139.", "ArticleIdList": ["PMC3148614", "21829786"]}, {"Citation": "Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, et al. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition. (2011) 27:206\u201313.", "ArticleIdList": ["PMC2952043", "20605696"]}, {"Citation": "Mousavi A, Vafa M, Neyestani T, Khamseh M, Hoseini F. The effects of green tea consumption on metabolic and anthropometric indices in patients with type 2 diabetes. J Res Med Sci. (2013) 18:1080\u20136.", "ArticleIdList": ["PMC3908530", "24523800"]}, {"Citation": "Toolsee NA, Aruoma OI, Gunness TK, Kowlessur S, Dambala V, Murad F, et al. Effectiveness of green tea in a randomized human cohort: Relevance to diabetes and its complications. Biomed Res Int. (2013) 2013:412379.", "ArticleIdList": ["PMC3786468", "24102055"]}, {"Citation": "Hua C, Liao Y, Lin S, Tsai T, Huang C, Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebocontrolled clinical trial. Altern Med Rev. (2011) 16:157\u201363.", "ArticleIdList": ["21649457"]}, {"Citation": "Senger AV, Schwanke C, Gomes I, Gottlieb MGV. Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly. J Nutr Health Aging. (2012) 16:738\u201342.", "ArticleIdList": ["23131813"]}, {"Citation": "Belcaro G, Ledda A, Hu S, Cesarone MR, Feragalli B, Dugall M. Greenselect phytosome for borderline metabolic syndrome. Evid Based Complement Altern Med. (2013) 2013:869061.", "ArticleIdList": ["PMC3848081", "24348726"]}, {"Citation": "Tsai C-H, Chiu W-C, Yang N-C, Ouyang C-M, Yen Y-H. A novel green tea meal replacement formula for weight loss among obese individuals: A randomized controlled clinical trial. Int J Food Sci Nutr. (2009) 60 (Suppl. 6):151\u20139.", "ArticleIdList": ["19736596"]}, {"Citation": "Yuan F, Dong H, Fang K, Gong J, Lu F. Effects of green tea on lipid metabolism in overweight or obese people: A meta-analysis of randomized controlled trials. Mol Nutr Food Res. (2018) 62:1601122.", "ArticleIdList": ["28636182"]}, {"Citation": "Chan CC, Koo MW, Ng EH, Tang O-S, Yeung WS, Ho P-C. Effects of Chinese green tea on weight and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome\u2014a randomized placebo-controlled trial. J Soc Gynecol Investig. (2006) 13:63\u20138.", "ArticleIdList": ["16378915"]}, {"Citation": "Chu S-I, Fu H, Yang J-X, Liu G-X, Dou P, Zhang L, et al. . A randomized double-blind placebo-controlled study of Pu\u2019er tea (\u666e\u6d31\u8336) extract on the regulation of metabolic syndrome. Chin J Integr Med. (2011) 17:492\u20138.", "ArticleIdList": ["21725873"]}, {"Citation": "Bursill CA, Roach PD. A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats. Lipids. (2007) 42:621\u20137.", "ArticleIdList": ["17582541"]}, {"Citation": "Cuccioloni M, Mozzicafreddo M, Spina M, Tran CN, Falconi M, Eleuteri AM, et al. Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase. J Lipid Res. (2011) 52:897\u2013907.", "ArticleIdList": ["PMC3073461", "21357570"]}, {"Citation": "Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. The major green tea polyphenol,(-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat\u2013fed mice. J Nutr. (2008) 138:1677\u201383.", "ArticleIdList": ["PMC2586893", "18716169"]}, {"Citation": "Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr. (2008) 62:953\u201360.", "ArticleIdList": ["17554248"]}, {"Citation": "Xu R, Bai Y, Yang K, Chen G. Effects of green tea consumption on glycemic control: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab. (2020) 17:56.", "ArticleIdList": ["PMC7350188", "32670385"]}, {"Citation": "Liu K, Zhou R, Wang B, Chen K, Shi L-Y, Zhu J-D, et al. Effect of green tea on glucose control and insulin sensitivity: A meta-analysis of 17 randomized controlled trials. Am J Clin Nutr. (2013) 98:340\u20138.", "ArticleIdList": ["23803878"]}, {"Citation": "Collins QF, Liu H-Y, Pi J, Liu Z, Quon MJ, Cao W. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5\u2032-AMP-activated protein kinase. J Biol Chem. (2007) 282:30143\u20139.", "ArticleIdList": ["PMC2408735", "17724029"]}, {"Citation": "Xiao J, Kai G, Yamamoto K, Chen X. Advance in dietary polyphenols as \u03b1-glucosidases inhibitors: A review on structure-activity relationship aspect. Crit Rev Food Sci Nutr. (2013) 53:818\u201336.", "ArticleIdList": ["23768145"]}, {"Citation": "Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr. (2006) 136:2512\u20138.", "ArticleIdList": ["16988119"]}, {"Citation": "Giggey PP, Wendell CR, Zonderman AB, Waldstein SR. Greater coffee intake in men is associated with steeper age-related increases in blood pressure. Am J Hypertens. (2011) 24:310\u20135.", "ArticleIdList": ["PMC5139684", "21088672"]}, {"Citation": "Essex K, Mehdi A, Shibeeb S. Green tea consumption does not adversely affect kidney function and haematological parameters. Food Public Health. (2019) 9:79\u201383."}, {"Citation": "Mohib MM, Rabby SF, Paran TZ, Hasan MM, Ahmed I, Hasan N, et al. Protective role of green tea on diabetic nephropathy\u2014A review. Cogent Biol. (2016) 2:1\u201323."}, {"Citation": "Rhee SJ, Choi JH, Park MR. Green tea catechin improves microsomal phospholipase A2 activity and the arachidonic acid cascade system in the kidney of diabetic rats. Asia Pacific J Clin Nutr. (2002) 11:226\u201331.", "ArticleIdList": ["12230237"]}, {"Citation": "Zhu D, Wang L, Zhou Q, Yan S, Li Z, Sheng J, et al. (+)-Catechin ameliorates diabetic nephropathy by trapping methylglyoxal in type 2 diabetic mice. Mol Nutr Food Res. (2014) 58:2249\u201360.", "ArticleIdList": ["25243815"]}, {"Citation": "Choi J-H, Chai Y-M, Joo G-J, Rhee I-K, Lee I-S, Kim K-R, et al. Effects of green tea catechin on polymorphonuclear leukocyte 5\u2019-lipoxygenase activity, leukotriene B4 synthesis, and renal damage in diabetic rats. Ann Nutr Metab. (2004) 48:151\u20135.", "ArticleIdList": ["15133320"]}]}], "History": [{"Year": "2023", "Month": "7", "Day": "5"}, {"Year": "2023", "Month": "11", "Day": "27"}, {"Year": "2024", "Month": "1", "Day": "2", "Hour": "11", "Minute": "44"}, {"Year": "2024", "Month": "1", "Day": "2", "Hour": "11", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "1", "Hour": "4", "Minute": "23"}, {"Year": "2023", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["38162524", "PMC10755896", "10.3389/fnut.2023.1253275"]}}]}